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ABSTRACT OF THE THESIS 
MANGIFERIN AS A BIOMARKER FOR  
MANGO ANTHRACNOSE RESISTANCE 
by 
Herma Pierre 
Florida International University, 2015 
Miami, Florida 
Professor Krishnaswamy Jayachandran, Major Professor 
Mangos (Mangifera indica L.) are tropical/subtropical fruits belonging to the 
plant family Anacardiaceae. Anthracnose is the most deleterious disease of mango both 
in the field and during postharvest handling. It is most commonly caused by the 
Colletotrichum gloeosporioides complex. Mangiferin, a xanthanoid compound found in 
at least twelve plant families worldwide (Luo et al., 2012), is present in large amounts of 
the leaves and edible mangos. Even though this compound plays a pivotal role in the 
plant’s defense against biotic and abiotic stressors, no correlations been made between 
the compound and mango anthracnose resistance. 
Mangos were collected, grouped according to their countries of origin, and 
evaluated for their mangiferin concentrations at four different stages of development. 
Extracts of interest were then tested against different strains of C. gloeosporioides. The 
results demonstrated that mangiferin concentrations are significantly different at different 
stages in fruit development. The antifungal assays were inconclusive. 
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I. INTRODUCTION 
 Mangos (Mangifera indica L.) are tropical/subtropical fruits that belong to the 
plant family Anacardiaceae. Known as the “king of fruits”, thousands of cultivars exist 
worldwide and mangos are one of the world’s most important fruit crops (Morton, 1987). 
Extensive plant breeding has led to the generation of over a thousand cultivars whose 
fruits show a pronounced diversity in color, shape, flavor, and texture (Berardini et al., 
2005) and its global production exceeded 26 million tons in 2004 (Barreto et al., 2004). 
The dry season stimulates the formation of mango blossoms. The wet, highly humid 
(>95%) season that follows stimulates the proliferation and development of a deleterious 
disease known as anthracnose (Nelson, 2008; Chang et al, 2012). Post-harvest losses 
attributable to this disease are substantial (Nelson 2008).  
Anthracnose is the most deleterious disease of mango both in the field and during 
postharvest handling. It is most commonly caused by a complex of fungi called the 
Colletotrichum gloeosporioides complex (C. gloeosporioides Penz. and Sacc. In Penz; C. 
asianum; and the nom. nov. C. queenslandicum), and in some cases, caused by C. 
acutatum J. H. Simmonds. Fruits without anthracnose lesions are not guaranteed to be 
anthracnose-free since the infections are quiescent (Chang et al, 2012; Karunanayake et 
al., 2011; Weir et al., 2012). 
Symptoms include dark lesions on the leaves, panicles, and petioles of the mango 
tree as well as sunken, prominent dark spots on the fruits. The dark spots on fruits 
typically coalesce and (ultimately) penetrate deep within the fruit which results in 
extensive rotting. As of 2008, the most resistant varieties in Florida were Zill and Haden; 
the most susceptible varieties were Irwin, Sensation, Kent, Keitt, and Tommy Atkins 
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(Nelson 2008). The resistance of some varieties to C. gloeosporioides has been attributed 
to the high concentrations of antifungal 5-substituted resorcinols in the peel and latex of 
mango (Karunanayake et al., 2011; Knödler et al., 2007). 
 Alkylresorcinols are compounds found in high concentrations in the peel and 
latex of mangos (Karunanayake et al., 2011; Knödler et al., 2007). These compounds 
have been reported to exhibit antioxidant and antigenotoxic properties. Recent studies 
have shown that alk(en)ylresorcinol composition consists of a complex pool of C15-, 
C17-, and C19-substituted resorcinols with various degrees of unsaturation (Knödler et 
al., 2007). 
 Mangiferin is a xanthanoid compound found in at least twelve plant families 
worldwide (Luo et al., 2012).  Present in large amounts in the leaves and edible mangos, 
this compound has been evaluated for numerous pharmacological applications including 
antibacterial, antitumor, anti-HIV, antioxidative, and antiviral (Masibo, He, 2008; Singh 
et al., 2012). Also, mangiferin protects the plant from various forms of biotic and abiotic 
stress (Luo et al, 2012). Even though mangiferin plays a pivotal role in the plant’s 
defense against biotic and abiotic stressors, no correlations been made between the 
compound and mango anthracnose resistance. 
The objectives of the present project were to (1) Determine the mangiferin content 
in the fruit exocarp at four different stages of fruit development of mangos originating in 
four different regions; (2) Determine if there was a statistical difference in mangiferin 
content between the different regions of origin; and (3) Determine if there was a 
correlation between mangiferin content and mango anthracnose resistance via antifungal 
assays against C. gloeosporioides Penz. and Sacc. In Penz. 
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Once the mangiferin content was quantified, the data were analyzed via a repeated 
measures analysis of variance (Repeated Measures ANOVA) to determine if there was a 
statistical difference in mangiferin content among regions as well as among mangiferin 
content at different stages of development with the two independent factors being Region 
and Stage of Development. 
Extracts of interest (containing incredibly high and low amounts of mangiferin) 
were analyzed for any antifungal capabilities against four different strains of C. 
gloeosporioides Penz. and Sacc. In Penz. A two-way ANOVA was utilized to determine 
if there was a statistical difference between antimicrobial activity between the four 
different strains of C. gloeosporioides Penz. and Sacc. In Penz. as well as between the 
extracts applied to the fungi.  
Mangiferin operates as a defensive compound against biotic and abiotic stressors. 
Consequently, it is probable that the compound is produced in higher amounts in regions 
where UV rays are at high levels and in areas that are conducive for microbial growth 
i.e., areas in and around the Equator. Therefore, it was hypothesized that the mangiferin 
content would the highest in Region 4 (Pacific/South America/West Indies) and the 
lowest in Region 2 (Florida/Hawaii/Israel) during all four stages of development and that 
there would be a negative correlation between fungus growth and mangiferin 
concentrations. The control cultivars ‘Neelum’ and ‘Zebda’ were reportedly highly 
susceptible and highly resistant to mango anthracnose, respectively. As such, it was 
hypothesized that the mangiferin content would be considerably low and considerably 
high, respectively. 
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II. MANGOS 
2.1 Introduction 
Mangos (Mangifera indica L.) are tropical/subtropical fruits that belong to the 
plant family Anacardiaceae. These fruits are famous for their delicious taste, intense peel 
color, strong aroma, and high amounts of bioactive compounds (e.g., phenolic 
compounds, minerals, and β-carotene. According to literature, mangos originated 
approximately 4000 years ago from the Indo-Burmese region (Luo et al, 2012). The 
Persians carried mangos to East Africa around the 10th Century A.D. then the Portuguese 
introduced it to West Africa and Brazil around the 16th Century. After being established 
in Brazil, the species was carried to Barbados in 1742 then to the Dominican Republic 
(Morton, 1987). Extensive plant breeding has led to the genesis of hundreds of cultivars 
worldwide. In fact, over the last 500 years, mangos have become well-established in 
tropical locations in the United States (e.g., Hawaii and Florida) and Florida is considered 
a secondary center for genetic diversity (Schnell et al., 2006). The different accessions of 
mango show diversity in color, shape, flavor, seed size, and composition (Berardini et al., 
2005).  
Mangos are grown commercially in more than 87 countries and its global 
production exceeded 26 million tons in 2004 (Barreto et al, 2004). According to the 
FAO, in 2010, India—the world’s largest producer of mangos—produced approximately 
15 million tons of mangos and had a 40.48% share in the world’s total production, 
followed by China which produced approximately 4.35 million tons of mangos and had 
an 11.72% share in the world’s total production, and Thailand which produced 
approximately 2.55 million tons of mangos. 
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2.2 Mango Chemical Constituents  
 Mangos are known to be excellent sources of different essential vitamins (e.g., β-
carotene, ascorbic acid, niacin, and riboflavin). The chemical composition of mangos 
depends on the variety, location of cultivation, and stage of maturity of the mango plant 
(Luo et al., 2012). Typically, the mango pulp consists of gallic acid, mangiferin, 
quercetin glycosides, and tannins (Schieber et al., 2000) 
 
2.3 Mango Fruit Development 
 Mango fruits exhibit simple sigmoid-type growth patterns and have three stages 
of growth. Stage I consists of the first two weeks from the fruit set and is characterized by 
a slow growth rate. Stage II consists of weeks 3 through 8 and is characterized by an 
increased growth rate. Stage III consists of weeks 13 through 16. In this stage, growth 
occurs at a slower rate until maturity. The duration of each stage varies by cultivar and is 
influenced by climatic, edaphic, and cultural factors (Ponce de León et al., 2000). 
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III. MANGIFERIN 
3.1 Structural Information 
Mangiferin (1,3,6,7-
Tetrahydroxyxanthone-C2-β-D-glucoside) 
(Figure 1) is a xanthanoid found in the plant 
species Mangifera indica and Anemarrhena 
asphodeloides. With a molecular weight of 422 
g/mol, mangiferin is widely distributed in 
approximately twelve higher plant families (Luo 
et al., 2012). This potent fungistatic compound 
is present in the leaves, stem bark, fruits, roots, and heartwood of mango trees 
(Chakrabarti, 2011; Rao et al., 2008; Singh et al., 2012). It is an important secondary 
metabolite that protects the plant against various biotic and abiotic stressors (Luo et al., 
2012).  
Polyphenols are known to capture free radicals via donating hydrogen atoms or 
electrons which neutralizes free radicals. The bioactivity of polyphenols may be related 
to its ability to chelate metals and inhibit lipooxygenases (Stoilova, et al., 2008). 
Lipooxygenases (i.e., oxidoreductases) are of the enzyme class 1.13.11. These iron-
containing enzymes catalyze the dioxygenation of polyunsaturated fatty acids in lipids 
containing a cis, cis-1,4-pentadiene structure. Lipooxygenases act on the CH-OH group 
of donors and act on single donors with the incorporation of molecular oxygen (Enzyme, 
2011). It has been reported that the synthesis and accumulation of phenolic compounds 
impart disease resistance in plants (Chakrabarti, 2011). 
 
 
Figure 1. Mangiferin 
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Arising from two different aromatization pathways—the Shikimate and Ketate 
(Acetate) pathways (Wauthoz et al., 2007)—mangiferin possesses eight hydroxyl groups: 
four are within the glucopyranosyl system and the other four are directly engaged on the 
xanthone skeleton (Gómez-Zaleta et al., 2006). With its fused ring formation, free 
rotation about the C-C bonds does not occur. When packing mangiferin, stabilization is 
credited to the hydrogen bonds of the hydroxyl (-OH) hydrogens present in the molecule 
and by crystallization of water molecules (hydroxyl acts as a hydrogen donor and 
acceptor) (da Cruz Jr. et al., 2008). It can be assumed that this characteristic attributes to 
the high melting point (270°C) of mangiferin. 
 
3.1.1 The Xanthone Backbone.  
As mentioned above, mangiferin is partly 
composed of a xanthone backbone (Figure 2). 
Xanthone is a heterocyclic compound with a boiling 
point of 350°C and a melting point of 174°C. These 
heat stable molecules are one of the most potent 
antioxidants known. In fact, these “super 
antioxidants” are thought to be more potent than vitamins C and E (Masibo, He, 2008). 
An unsubstituted xanthone ring is not known to occur in nature (Thomasek, Crawford, 
1986).  
Figure 2. Xanthone Backbone. 
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3.1.2 The Catechol Moiety.  
Mangiferin bears a catechol moiety (pyrocatechol or 1,2-dihydroxybenzene) 
(Figure 5) which is a pharmacophore with a well-established anti-oxidant property. 
Pharmacophores are a set of structural features in a molecule recognized at a receptor site 
responsible for a molecule’s biological activity (Volpato et 
al., 2009). Catechol moieties scavenge highly reactive 
species (e.g., peroxynitrile). Mangiferin activity (which 
involves the enzyme polyphenol oxidase along with the 
catechol moiety) gives rise to oxidized products like 
semiquinone radicals and quinones (Figures 3 and 4). 
These products present potential toxicity owing to their oxidant capacities. Semiquinones 
are potentially toxic compounds, especially in virtue of their ability to arylate protein 
thiol groups. Quinones are weak electrophiles that can deplete cellular thiols via the 
Michael Addition reaction to form dithioethers and via peroxide-mediated oxidation to 
form disulfides. Catechol can readily condense to form heterocyclic compounds. For 
instance, catechol produces quinones with the addition of cyanide (CN). Catechol 
moieties are present in numerous flavonoids and in catecholamines. Small amounts of 
 
Figure 5. Catechol moiety. 
  
Figure 3. Semiquinone radical.  
 
 
Figure 4. An example of a quinone: 1,4-
Benzoquinone. 
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catechol also occur in fruits and vegetables along with the enzyme polyphenol oxidase 
(reacts to form benzoquinone) (Andreu et al., 2005). 
3.2 Mangiferin Identification 
 Mangiferin can be identified using 
an array of techniques such as high 
performance liquid chromatography 
(HPLC), nuclear magnetic resonance 
(NMR), UV-vis spectroscopy, the Folin 
Ciocalteau method, and mass spectrometry 
(MS). The present project utilizes HPLC to 
separate the components of the extract, UV-
vis spectroscopy to confirm the presence of the compound of interest, and MS to identify 
the mangiferin and confirm its presence in the extract. 
 Ultraviolet-visible (UV-vis) spectroscopy is an analytical technique involving 
absorbance spectroscopy in the ultraviolet-visible spectral range. Absorbance of radiation 
is measured as a function of frequency or wavelength because of its interaction with a 
sample. Absorbance occurs with conjugated compounds. The extent and location of 
conjugation determines the type of absorption that occurs. It also affects the amount of 
energy (in the form of waves) that is absorbed by the compound (for an example, see 
Figure 6).  
 Mangiferin has lambda maxes at 240nm, 230-260nm, 317nm, and 366nm (Figure 
7). Absorbance at 240nm is the result of the medium energy π-π* transition of the 
aromatic ring. Absorbance at 230-260nm is the result of a π-π* transition in the s-trans 
 
Figure 6. Example of the effect of 
conjugation on absorbance. 
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enone system by the cyclic β-diketone presence. Absorbance at 317nm is related to the n-
π* transitions of the aromatic ring. Absorbance at 366nm is caused by the intramolecular 
charge-transfer absorption (Gómez-Zaleta et al. 2006). 
 
 
 
Figure 7. UV absorbance of mangiferin. 
 
 
Figure 8. Mangiferin MS/MS fragmentation pattern. 
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Mass spectrometry is an analytical technique that helps to identify the amount and 
type of analytes present in a sample by measuring the mass-to-charge (m/z) ratio and 
abundance of gas-phase ions. Atoms or molecules in a sample can be identified by 
correlating known masses to identified masses or a characteristic fragmentation pattern. 
Mangiferin has a parent peak at 423 m/z, a base peak at 405 m/z, and 
characteristic peaks at 387 m/z, 357 m/z, 327 m/z, and 303 m/z (Figure 8). The fragments 
405 m/z and 387 m/z may be because of the hydrolysis of the hydroxyl groups that 
comprise the catechol moiety. The other fragments can be explained by the proposed 
fragmentation scheme constructed by Sun et al. (2009) (Figure 9). 
 
3.3 Biological Role in the Plant 
Mangiferin is synthesized in the leaves of mango trees and stored in the bark. 
When a species is inflicted with any form of stress (e.g., cut injury or infection by a 
pathogen), mangiferin is produced along with its aglycone, norathyriol, and accumulates 
in the injured organs. Mangiferin is a major constituent of young leaves as well as the 
 
Figure 9. Proposed Fragmentation Pattern of Mangiferin by Sun et al. (2009). 
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bark of mango trees. It is also utilized in forming new shoots and leaves and is transferred 
to growing regions during flushing. The compound also serves as a micronutrient carrier 
molecule. 
3.4 Report on Mangiferin’s Role Against Fusarium spp. 
 Mangiferin is a potential biochemical indicator for screening mango genotypes to 
malformation disease (Fusarium mangiferae Britz., M.J. Wingf. & Marasas). Whenever 
Fusarium spp. is present, mangiferin halts the ingress of the fungi into host organelles by 
oxidizing into polymeric quinones (along with gallic acid conjugates). These quinones 
cause the collapse of adjoining cells. The collapsing of adjoining cells removes the 
nutrition source of the fungus and therefore prevents the multiplication of the fungus. 
Mangiferin also stops the breakdown of host starch. This process removes the nutrition 
source the pathogen requires to grow and sporulate. Mangiferin stimulates fungal growth 
at lower concentrations and inhibits growth at higher concentrations. In fact, 
malformation-resistant mango cultivars have been reported to have higher mangiferin 
contents. Inversely, if mangiferin accumulates excessively at the site of infection, this 
results in the manifestation of disease symptoms via a wide range of biological and 
physiological aberrations in the host cells. Accumulated mangiferin causes (1) an 
increased IAA (indole-3-acetic acid) content which results in an increase in vegetative 
growth, (2) increased chlorophyll content which causes malformed shoots or panicles to 
look greener, (3) increased photosynthesis which leads to more carbohydrate synthesis, 
(4) reduced respiration and amylase activity which causes carbohydrate accumulation, 
thereby disturbing the C/N ratio, (5) reduced catabolism which increases longevity, and 
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(6) reduced transpiration which causes a high moisture content. Mangiferin also induces 
significant morphological and physiological changes in the Fusarium pathogen, thereby 
creating a new physiological race (Chakrabarti, 2011). 
IV. MANGO ANTHRACNOSE 
 
Anthracnose is the most deleterious disease of mango trees both in the field and 
during postharvest handling. It is most commonly caused by the teleomorph Glomerella 
cingulata (Stoneman) Spauld. & H. Schrenk (anamorph: Colletotrichum gloeosporioides 
Penz. and Sacc. In Penz) and in some cases caused by C. acutatum J. H. Simmonds. 
Spores germinate and form penetration pegs soon after landing on the peel of unripe 
fruits. Dormant hyphae remain in intercellular spaces of the peel and cause no damage 
until the onset of germination during the ripening process. Germination is induced by the 
release of ethylene by the host. Ethylene is a ripening hormone which induces formation 
of appressoria (flattened, hyphal “pressing” organ), spore germination, and branching of 
germ tubes. As such, further development of the fungus is halted until ripening occurs. 
 
Figure 10. Healthy mango (left) and mangos infected with anthracnose (right) (Nelson, 2008). 
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Fruits without anthracnose lesions are not guaranteed to be anthracnose-free (Chang et al, 
2012). Symptoms include black, sunken, rapidly proliferated lesions on organs affected 
by the fungus. 
Colletotrichum gloeosporiodes Penz and Sacc. is the anamorphic stage (asexual 
stage) of the pathogen. Its life cycle (Figure 6) begins with dissemination. Spores (or 
conidia) of the pathogen are dispersed passively via splashing rain or irrigation water. 
Inoculation then follows. It involves the landing of spores on infection sites (e.g., leaves, 
panicles, and fruit). In young fruit and immature tissue, when the spores are inoculated, 
they germinate, penetrate through the tissue cuticle and epidermis, and ramify the tissues. 
On more mature fruit, infections penetrate the tissue cuticle but the disease remains 
quiescent until the fruits begin to ripen. Disease development becomes apparent when 
black, sunken, lesions develop on infected organs and rapidly spread. Sticky masses of 
 
Figure 11. Colletotrichum gloeosporioides infection cycle (Nelson, 2008). 
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conidia form in acervuli (tiny cushion-like structure consisting of a mass of hyphae-
bearing asexually produced spores) on symptomatic tissue and the cycle begins again 
(Nelson, 2008). 
The dry (cold) season stimulates the formation of mango blossoms. The wet, 
highly humid (>95%) season that follows stimulates the proliferation and development of 
a deleterious disease known as anthracnose (Nelson, 2008; Chang et al, 2012). Post-
harvest losses as a result of this disease are substantial (Nelson 2008). 
The C. gloeosporioides strains that affect mangos are genetically and 
pathologically distinct populations of this species. The mango population has not been 
found on other tropical fruit crops and is highly virulent only on mangos (i.e., the strains 
have restricted host ranges) (Nelson 2008). It has been reported that the cultivars that are 
very susceptible to mango anthracnose include ‘Willard’, ‘Neelum’, ‘Pirie’, and 
‘Kensington’. The varieties reported to be resistant include ‘Saigon’, ‘Carrie’, ‘Paris’ and 
‘Zebda’ (Litz, 2009; Nelson, 2008).  
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V. MATERIALS AND METHODS 
5.1 Materials 
5.1.1 Sample Preparation 
During sample preparation the following apparatus and reagents were utilized: an 
analytical balance, 50mL disposable centrifuge tubes (Fisher Scientific cat#: 05-539-12), 
liquid nitrogen, dewar vessels, metal mortars, ceramic pestles, funnels, spatulas, and 
surgical steel blades 
5.1.2 Sample Processing 
During sample processing the following apparatus and reagents were utilized: 
50:50 acetonitrile:water, 15mL disposable centrifuge tubes, 5mL Class A volumetric 
pipettes, a vortex, a sonicator, a shaker, and a centrifuge. 
5.1.3 Sample Fortification 
During sample fortification the following apparatus and reagents were utilized: 
2mL and 4mL Class A volumetric pipettes, 50mL volumetric flasks, brown bottles, 50:50 
acetonitrile:water, and a 5000ppm mangiferin stock solution in 50:50 acetonitrile:water. 
 
 
5.1.4 Instrumental Analysis 
During instrumental analysis the following apparatus and reagents were utilized: 
Thermo Scientific UltiMate™ 3000 UPLC equipped with a photodiode array detector, 
Thermo Scientific LTQ Heated Electrospray Ionizer (HESI) coupled with a Line Ion Trap 
Mass Spectrometer; analytical column: Zorbax 300SB-C18 250 x 4.6mm (5µm), 0.1% 
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formic acid in HPLC-grade water, 0.1% formic acid in acetonitrile, 15mL disposable 
centrifuge tubes, autosampler vials, 50:50 acetonitrile:water; and 0.5, 1, 2, 3, 8, and 
10mL Class A volumetric pipettes. 
5.1.5 Antifungal Assay 
The following apparatus and reagents were used: potato dextrose agar, deionized 
water, 1 L bottles, 1000µL pipettes, concentrated lactic acid (85%), petri dishes, and an 
autoclave. 
 
5.2 Sampling 
 
 Schnell et al. (2006) constructed a UPGMA (Unweighted Pair Group Method 
with Arithmetic Mean) dendrogram for 10 geographical groups that contained at least 
four genotypes of 
Mangifera indica as well 
as two other Mangifera 
species (Figure 5) using 
Rogers’ distance that 
were derived from 
microsatellite marker 
allele frequencies. The 
Mangifera species were 
separated into three 
clusters and the M. indica species was further separated into four clusters. Populations 
 
Figure 12. Dendrogram of ten geographical groups of mangos 
(Schnell et al., 2006). 
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from Africa, India, and Central America clustered into one group, Florida, Hawaii, and 
Israel in another group, Southeast Asian populations in their own cluster, and the Pacific, 
South America, and the West Indies populations in a group. The M. indica clusters in the 
dendrogram were utilized as a template to group samples into four “regions”. Using a 
random number generator, 16 cultivars were randomly selected (Table 1)—4 from each 
region—from the cultivars located at the United States Department of Agriculture-
Agricultural Research Service/Subtropical Horticulture Research Station that produced 
enough fruit for collection. In addition to these cultivars, accessions that were reported to 
be highly susceptible and highly resistant to anthracnose were sampled: Neelum and 
Zebda, respectively. These varieties were put into a group labeled “Region 0”. 
 Samples were collected at four different stages of the mango fruit development. 
Approximately 8 weeks post-fruit set, two fruit were randomly collected from each tree, 
appropriately labeled, and stored in a -80°C to await analysis. These samples were at 
“Stage I” of development. The process was repeated every two weeks over a six week 
period and those samples were at stages II through IV of development, respectively. A 
total of 128 fruit were collected.  
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Table 1. Cultivars analyzed and their origins. 
Region Locations Cultivar 
1 
Pacific 
South America 
West Indies 
Peach 
Pere Louis 
Turpentine #7 
Toledo 
2 Southeast Asia 
Nam Tan Teen 
Nam Doc Mai 
Myatryaut 
Katar Rum Rung 
3 
Florida 
Hawaii 
Israel 
Tommy Atkins 
Fukuda 
Bombay 
Maya 
4 
Africa 
India 
Central America 
Sabre 
Diab 
Bullock’s Heart 
Jehangir 
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5.3 Method Validation: Limit of Detection and Limit of Quantitation Determination 
 Method validation is the process used to confirm than an analytical procedure 
utilized for a specific test is suitable for its intended use. 
5.3.1 Limit of Detection and Limit of Quantitation Determination 
 The Limit of Detection (LOD) is the lowest quantity of an analyte that can be 
distinguished from the absence of that analyte (i.e., a blank). The Limit of Quantitation 
(LOQ) is the limit at which the difference between two values can be distinguished. To 
determine the LOD and LOQ, a technique recommended by the International Conference 
on Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) 
Q2B Methodology guideline on analytical method validation was used. The LOD and 
LOQ was determined both “out-of-matrix” and “in-matrix”. The results acquired for the 
“out-of-matrix” and “in-matrix” standards was used to determine if there was any 
enhancement or suppression due to the matrix. 
5.3.2 “Out-of-Matrix” Determination  
The following standards of mangiferin were prepared in 50:50 Acetonitrile: 
Water: 50ppm, 150ppm, 250ppm, 350ppm, and 500ppm. The five standards were 
injected in triplicate on the UPLC-ESI-MS (Injection volume: 1µL). Using Microsoft 
Excel®, a regression of the peak areas of the standards was acquired. From the statistics, 
the LOD and LOQ for mangiferin was determined using the following equations: 
Equation 1. Limit of Detection Calculation. 
ܮܱܦ = 3.33(ߪݏ) 
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Equation 2. Limit of Quantitation Calculation. 
ܮܱܳ = 10(ߪݏ) 
where σ is the standard deviation of the y-intercept and S is the slope of the line. 
5.3.1 “In-Matrix” Determination 
Five extracts were prepared as directed by the analytical procedure. In microliter 
amounts, each extract was spiked, each at different levels for final concentrations of 
50ppm, 150ppm, 250ppm, 350ppm, and 500ppm, respectively. The five spiked extracts 
were injected in triplicate on the UPLC-ESI-MS (Injection volume: 1µL). Using 
Microsoft Excel®, a regression on the data was acquired. From the statistics, the LOD 
and LOQ for mangiferin was determined using Equation 1 and Equation 2. 
5.4 Method Validation: Determination of Linearity and Range 
 Linearity is the ability of a method to elicit test results that are directly—or by a 
well-defined mathematical transformation—proportional to an analyte’s concentration 
within a given range. The range is the interval between the upper and lower levels of 
analyte that have been demonstrated to be determined with precision, accuracy, and 
linearity using the analytical procedure as written. 
 The range of the analytical procedure was established to be from the Limit of 
Quantitation (LOQ) to 10 times LOQ. The linearity was then determined across the entire 
range of an analytical method by preparing five concentrations of mangiferin to be 
analyzed (LOQ, 2LOQ, 5LOQ, 7LOQ, and 10LOQ). The concentrations were analyzed 
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in triplicate by the UPLC-ESI-MS (Injection volume: 1µL). A regression analysis was 
prepared using Microsoft Excel®. 
 
5.5 Method Validation: Accuracy Determination 
 Accuracy is the measure of exactness of an analytical method, the closeness of 
agreement between the conventional, or the true value or accepted reference value and 
the observed value. In other words, it is a measure of systematic errors. Accuracy is 
measured by the percentage of analyte recovered from spiked samples. 
 A group of blank samples were prepared for accuracy determination. The group 
consisted of a solvent blank, three replicates of the matrix blank, and three replicates of 
the matrix blank spiked at five levels (LOQ, 2LOQ, 5LOQ, 7LOQ, 10LOQ). A total of 
18 samples were prepared for analysis.  
Fortified standards were prepared and used to spike the matrix blanks prior to the 
extraction. Samples were extracted and analyzed using the analytical procedure being 
validated. The average percent recovery was calculated for each spike level as well as the 
standard deviation and coefficient of variance. 
 
5.6 Technical Procedure  
5.6.1 Scope 
 The extraction method that was used was applicable to the quantitative 
determination of mangiferin in mango peels. The method had a validated LOD of 13.32 
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ppm and a LOQ of 39.99 ppm and was validated over a concentration range of 39.99 
ppm-399.9 ppm. The method generated approximately 4 mL of organic waste per sample. 
 
5.6.2 Principle 
A 1 g sample was extracted with 50:50 acetonitrile:water. The extract was 
sonicated for 15 min, placed on a shaker overnight, vortexed, and centrifuged for 5 min 
(4500 rpm). An aliquot of the sample was diluted 1:4, transferred to an autosampler vial, 
and analyzed by an Ultra High-Performance Liquid Chromatograph coupled with a 
Heated Electrospray Ionizer-Mass Spectrometer with UV detection at 242nm, 367nm, 
and 3D Field as well as MS-MS detection of the base peak 405 m/z.  
 
5.6.3 Process Description 
 5.6.3.1 Sample Preparation 
I. Mixing and Preparation of Samples 
 Using a surgical steel blade, viable peel (peel that was unbroken with no 
fungi visibly growing on it) was removed from the mango fruit. Using a metal 
mortar and ceramic pestle, the peel was ground into a homogeneous powder in 
liquid nitrogen. The ground tissue was then transferred into a 50 mL disposable 
centrifuge tube and stored in a cryogenic freezer to await extraction. 
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II. Weighing of Sub-Samples 
 Before weighing sub-samples, the suitability of the balance was verified 
and the appropriate documentation was recorded in the balance logbook. Once 
this step was completed, a 50 mL disposable centrifuge tube was placed into a 
beaker and the analytical balance was tared. One gram of the sample was 
transferred into the 50 mL centrifuge tube and the weight was recorded on the 
sample worksheet. 
 
 5.6.3.2 Sample Processing 
 To the sample, 5 mL of 50:50 Acetonitrile was added. The sample was 
then sonicated for 15 minutes and placed on a shaker overnight (setting: low). The 
sample was then vortexed and centrifuged for 5 min (setting: 4500 rpm). The 
supernatant was transferred to a 15 mL disposable centrifuge tube and centrifuged 
for 5 min (setting: 4500 rpm). Approximately 0.5 mL of the supernatant was then 
transferred to a HPLC vial and 1.5 mL of 50:50 acetonitrile:water was added to 
the vial. 
 
 5.6.3.3 Sample Fortification 
I. Preparation of Fortification Solution 
 Using an eppendorf pipette, 1.4 mL of a 5000 ppm mangiferin stock 
solution was transferred to a 50 mL volumetric flask and diluted to mark with 
50:50 acetonitrile:water. The concentration was approximately 140 ppm. The 
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solution was transferred to an appropriate sized brown bottle and labeled. The 
activity was recorded on the sample worksheet. 
 
II. Preparation of Standard Check 
 The standard that was used was the LOQ. For LOQ standard preparation, 
please see section 5.6.3.4. 
 
III. Determination of Percent Recovery of Mangiferin 
 Every group that was extracted and analyzed was accompanied by a blank 
composite sample and a spiked (fortified) sample to determine the percent 
recovery for that day’s extraction. The fortified sample was prepared by spiking a 
composite sample with 5 mL of the fortified solution prepared in section 
4.6.3.3(I). Once the HPLC analysis was completed, the following calculations 
were used to determine the percent recovery: 
Equation 3. Percent Recovery Calculations. 
ܲ݁ݎܿ݁݊ݐ	ݎ݁ܿ݋ݒ݁ݎ݁݀ = ܣ݉݋ݑ݊ݐ	݂݋ݑ݊݀	(݌݌݉)ܣ݉݋ݑ݊ݐ	ݏ݌݅݇݁݀(݌݌݉) ݔ100% 
 5.6.3.4 Instrumental Analysis 
I. Preparation of Bench Standards 
 Using a class A volumetric pipette, 2 mL of the 5000 ppm stock solution 
of mangiferin was transferred to a 15 mL disposable centrifuge tube and then 8 
mL of 50:50 acetonitrile:water was added to the tube. The concentration was 
approximately 1000 ppm with a shelf life of 6 months. This solution was the 
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bench intermediate. This solution was used to create the following bench 
standards: LOQ, 5LOQ and 10LOQ. The concentrations of the bench standards 
were approximately 40 ppm, 200 ppm, and 400 ppm, respectively.  
 To prepare the LOQ standard, 0.5 mL of the bench standard was diluted to 
12.5 mL with 50:50 acetonitrile:water. To create the 5LOQ standard, 1.0 mL of 
the bench intermediate was diluted to 5.0 mL with the same solvent mixture. To 
create the 10LOQ standard, 2.0 mL of the bench intermediate was diluted to 5.0 
mL with the same solvent mixture. 
 
II. System Suitability 
Prior to analysis, the system was checked for its ability to analyze samples 
within the parameters deemed “acceptable” by the user (i.e., suitability). The 
standard check (see section 5.6.3.3(I)) was injected three tiems then the RSD of 
the three injections was calculated. The RSD had to be less than or equal to 5% in 
order for the system to be suitable. By injecting the standard in triplicate, the 
reproducibility of the system was determined. Once the RSD for the standard 
check was less than or equal to 5%, the bench standards (LOQ, 5LOQ, 10LOQ) 
were injected into the UPLC-MS and a standard curve was created. The R2 value 
of the curve had to be ≥ 0.98 in order for the system to be suitable. If these criteria 
were not met, maintenance was performed and the standard check and standard 
curve were analyzed again. Sample analysis was not performed until system 
suitability was achieved. 
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III. Analysis 
The 5LOQ standard was placed after every 5 samples and at the end of 
analysis. Samples found to be outside of the calibration curve (i.e., the calculated 
concentrations of the samples were more than 30% of the 10LOQ or less than 
30% of the LOQ) were diluted appropriately and the dilution factor was applied to 
the final amount. 
To calculate the amount of mangiferin, the following calculation was 
used: 
Equation 4. Mangiferin Content Calculation. 
ܣ݉݋ݑ݊ݐ	݋݂	݂݉ܽ݊݃݅݁ݎ݅݊ = (ܣ݉݋ݑ݊ݐ	݂݋ݑ݊݀	(݌݌݉)	ݔ	ܦ݈݅ݑݐ݅݋݊	݂ܽܿݐ݋ݎ)ܴ݁ܿ݋ݒ݁ݎݕ	ܨܽܿݐ݋ݎ  
 
IV. Analytical Method 
Separations were performed on a Thermo Scientific UltiMate™ 3000 
UPLC coupled with a Thermo Scientific LTQ Heated Electrospray Ionizer (HESI) 
Linear Ion Trap Mass Spectrometer was utilized for analysis. The column used 
was a Zorbax 300SB-C18 column (250 x 4.6mm, 5µm) set at 35°C.  Mangiferin 
was detected in the eluent with a UV photodiode array detector (Thermo 
Scientific) set at 242nm, 367nm, and 3-D Field.  The extract (1µL) was diluted 
1:4 and injected into the HPLC-MS. The mobile phase consisted of 0.1% formic 
acid in water (Eluent A) and 0.1% formic acid in acetonitrile (Eluent B) with a 
flow rate of 0.500 mL/min.  The following gradient was utilized over a run time 
of 19 min: initially 95% A for 1 min; to 100% B in 4 min; held for 4 min; to 95% 
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A in 7 min; and held for 3 min. The polarity of the mass spectrometer was 
positive. Two scan events were employed. During the full scan mode, the 
normalized collision energy was 35.0V, capillary temperature was 320°C, the 
source fragmentation was off, the data type was profile, and the masses scanned 
ranged from 115 m/z to 455 m/z. During the second scan event, the parent mass 
was identified as 423 m/z, the normalized collision energy was 20.0V, the source 
fragmentation was set at 35.0V, and masses scanned ranged from 115 m/z  to 430 
m/z. Peak integration was performed using Genesis.  
 
5.6.3.5 Antifungal Assay 
Four strains of Colletotrichum gloeosporioides Penz. and Sacc. In Penz 
were obtained from the University of Florida Tropical Research and Education 
Center (UF-TREC). Extracts from stage 4 of development from the cultivars 
Zebda, Neelum, Tommy Atkins, and Fukuda were tested in triplicate against these 
strains via disk diffusion assays on acidic PDA plates. Zones of inhibition were 
documented and a Two-Way ANOVA was implemented to determine if there was 
a correlation between any antifungal properties exhibited and mangiferin content 
in the peel extracts of the selected cultivars. To create the acidic PDA plates, 39g 
of PDA was added to a 1 L bottle followed by 1L of deionized water. The mixture 
was autoclaved and cooled to 50-60°C. Once the mixture cooled to the 
appropriate temperature, 1 mL of concentrated lactic acid (85%) was stirred into 
the mixture. The media were then poured into petri dishes and allowed to solidify 
before storing in a cool, dark location. 
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VI. RESULTS 
6.1 Method Validation 
6.1.1 Determination of the Limit of Detection and Quantitation 
 To determine the limit of detection (LOD) and limit of quantitation (LOQ), a five-
point calibration plot was constructed using standards at the following concentrations: 
50ppm, 150ppm, 250ppm, 350ppm, and 500ppm (Figure 13).  Linearity was achieved 
with a R2 value of 0.9518. The LOD was determined to be 61.45 ppm and the LOQ was 
determined to be 184.5ppm. The standard at the highest level deviated from linearity.  As 
such, another calibration plot was by constructed by omitting the values obtained for the 
500ppm standard (Figure 14). Linearity was achieved with a R2 value of 0.9969. The 
LOD was determined to be 13.32ppm and the LOQ was determined to be 39.99ppm. As 
such, the bench standards that were prepared to create a calibration plot prior to each 
HPLC-MS analysis and the standards used to determine the accuracy of the method were 
at the following levels: 40ppm (LOQ), 200ppm (5LOQ), and 400ppm (10LOQ). 
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Figure 13. Initial 5-point calibration plot used to determine the limits of detection 
and quantitation. 
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Figure 14. Final calibration plot used to determine the limits of detection and 
quantitation. 
6.1.2 Accuracy Determination 
 Mango peel composites were spiked at the following levels: LOQ (40 ppm), 
2LOQ (80 ppm), 5LOQ (200 ppm), 7LOQ (280 ppm), and 10LOQ (400 ppm) (Table 2). 
The mango peel composites spiked with standards at the LOQ level had the lowest mean 
percent recovery at 55.49%. Mango peel composites spiked with standards at the 5LOQ 
level had the highest mean percent recovery at 164%. The average percent recovery for 
all levels analyzed was 87.37% with a coefficient of variance of 0.56. With the exception 
of the LOQ, all coefficients of variance values were below 0.15.  
 
Table 2. Percent recoveries of mangiferin at levels over the 40ppm-400ppm range. 
  Mangiferin 
(ppm) 
% Recovery Average SD CV
Comp 22.609 -- 21.84991366 3.026 0.139
y = 4028.6x + 23915
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Comp 24.424 --     
Comp 18.516 --     
LOQ 22.996 57.515% 55.49% 0.235 0.42
LOQ 24.815 31.033%     
LOQ 31.149 77.909%     
2LOQ 91.139 113.976% 113.36% 0.012 0.01
2LOQ 91.293 114.168%     
2LOQ 89.518 111.949%     
5LOQ 336.769 168.461% 164.00% 0.042 0.03
5LOQ 326.809 163.479%     
5LOQ 319.944 160.045%     
7LOQ 387.273 129.130% 116.95% 0.163 0.14
7LOQ 369.812 123.308%     
7LOQ 295.153 98.414%     
10LOQ 354.603 88.678% 83.59% 0.045 0.05
10LOQ 327.081 81.795%       
10LOQ 321.049 80.287%       
 
6.2 Mangiferin Quantification 
 XCalibur software constructed reports that included a Total Scan PDA 
chromatogram, a MS/MS chromatogram highlighting the compound of interest, the 
fragmentation pattern of the compound of interest, and the calibration plot used to 
quantify mangiferin for each sample analyzed. An example of the report is located in the 
Appendix. 
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Figure 15. Mean mangiferin content per stage of development. 
 
Mangiferin content varied across cultivars as well as in each stage of development 
(Figure 15). The mangiferin content decreased exponentially as the fruit developed over 
time. The content was the highest at the first stage of development and the lowest at the 
fourth stage of development. The test variety with the highest amount of mangiferin with 
the least amount of variability at each stage of development was ‘Tommy Atkins’. This 
cultivar had average mangiferin concentrations of 21216ppm, 5663.8ppm, 4611.0ppm, 
and 3701.8ppm during stages 1, 2, 3, and 4 of development, respectively. The test variety 
with the lowest amount of mangiferin with the least amount of variability at each stage of 
development was ‘Fukuda’. The cultivar had mean mangiferin concentrations of 
48.813ppm, 8.4974ppm, 22.792ppm, and 6.3784ppm during stages 1, 2, 3, and 4 of 
development, respectively. Both cultivars were from Region 3 and originated from 
Florida and Hawaii, respectively. 
Region
Average (ppm) Standard Error Average (ppm) Standard Error Average (ppm) Standard Error Average (ppm) Standard Error
Peach 1 7401.5 3470 2786.1 967.7 2186.7 847.6 817.74 212.1
Pere Louis 1 381.10 306.0 151.02 115.9 194.94 129.1 439.36 162.1
Turpentine #7 1 16187 5316.8 4438.8 587.4 4846.7 1060 2602.4 25.56
Toledo 1 2960.2 60.957 1664.6 276.3 2076.5 667.0 1563.6 232.7
Nam Tan Teen 2 4349.2 645.88 3896.6 5287 616.81 333.9 824.52 231.3
Nam Doc Mai 2 883.63 789.69 356.63 413.2 135.54 133.7 46.526 4.452
Myatryaut 2 735.86 741.84 1093.2 363.2 767.00 588.8 151.74 28.65
Katar Rum Rung 2 1281.8 543.92 2420.0 1560 2023.0 112.0 1318.2 334.8
Tommy Atkins 3 21216 497.47 5663.8 19.57 4611.0 690.0 3701.8 385.5
Fukuda 3 48.813 8.9295 8.4974 0.4314 22.792 1.776 6.3784 0.060
Bombay 3 55.740 16.439 31.758 12.18 35.094 6.245 14.848 7.824
Maya 3 11568 8751.1 3605.4 728.4 2424.3 929.8 1121.9 93.33
Sabre 4 1050.0 318.01 99.613 39.79 1139.6 664.3 201.78 40.06
Diab 4 1318.0 359.05 597.49 263.4 3832.2 186.1 382.12 62.71
Bullock's Heart 4 1968.1 917.84 4404.6 463.7 165.42 49.82 617.67 504.0
Jehangir 4 280.84 70.432 773.96 56.18 600.37 750.6 363.94 197.9
Zebda 0 26735 2561.2 21610 3058 11639 1073 14481 1456
Neelum 0 27491 115.84 13718 1936 14489 1837 16124 286.1
Stage 1 Stage 2 Stage 3 Stage 4
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The control variety ‘Neelum’ (which reportedly exhibits high susceptibility to 
anthracnose) had the highest amount of mangiferin at during the first, third, and fourth 
stages of development at 27491ppm, 14489ppm, and  16124ppm, respectively with the 
control variety ‘Zebda’ (which reportedly exhibits high resistance to anthracnose) 
following close behind at 26735ppm, 11639ppm, and 14481ppm, respectively. ‘Zebda’ 
had the highest amount of mangiferin during the second stage of development at 
21610ppm with ‘Neelum’ following close behind at 13718ppm. ‘Neelum’ originates 
from India and ‘Zebda’ originates from Egypt. 
 The descriptive statistics for each region at each stage of development can be 
found in Table 3 and Figures 16-19. Regions that exhibited the highest and lowest 
concentration of mangiferin varied per stage of fruit development. Region 1 had the 
highest amount of mangiferin during stages 3 and 4 of development. Region 3 had the 
highest amount of mangiferin during stages 1 and 2 of development. Region 2 had the 
lowest amount of mangiferin during stage 3 of development. Region 4 had the lowest 
amount of mangiferin during stages 1, 2, and 4 of development. 
 
 
 
 
 
 
 
Table 3. Descriptive Statistics of Each Region per Stage of Development. 
 
 Region Statistic Std. Error 
Stage 1 0 Mean 27112.90207 771.622802
Std. Deviation 1543.245603  
1 Mean 6732.53581 2424.687581
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Std. Deviation 6858.052123  
2 Mean 1812.61280 588.029074
Std. Deviation 1663.197384  
3 Mean 8222.12665 3545.340362
Std. Deviation 10027.736845  
4 Mean 1154.24887 267.367543
Std. Deviation 756.229611  
Stage 2 0 Mean 17664.38425 2506.348645
Std. Deviation 5012.697290  
1 Mean 2232.00068 605.383562
Std. Deviation 1712.283288  
2 Mean 1941.61602 898.898827
Std. Deviation 2542.469824  
3 Mean 2327.35815 919.579861
Std. Deviation 2600.964621  
4 Mean 1468.91363 651.375213
Std. Deviation 1842.367321  
Stage 3 0 Mean 13063.97847 1026.486406
Std. Deviation 2052.972813  
1 Mean 2168.18295 661.350513
Std. Deviation 1870.581729  
2 Mean 885.57657 279.462133
Std. Deviation 790.438276  
3 Mean 1773.31209 737.574549
Std. Deviation 2086.175860  
4 Mean 1434.41607 556.240825
Std. Deviation 1573.286638  
Stage 4 0 Mean 15302.22567 638.962904
Std. Deviation 1277.925808  
1 Mean 1368.77383 313.613646
Std. Deviation 887.033344  
2 Mean 585.23720 203.167681
Std. Deviation 574.644980  
3 Mean 1211.24797 572.360990
Std. Deviation 1618.881350  
4 Mean 391.37618 92.069223
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Std. Deviation 260.411088  
 
 
 
 
 
Figure 16. Stage 1: Mangiferin content 
per region. 
 
Figure 17. Stage 2: Mangiferin content 
per region. 
 
Figure 18. Stage 3: Mangiferin content 
per region. 
 
Figure 19. Stage 4: Mangiferin content 
per region. 
6.3: Statistical Analysis: Repeated Measures ANOVA 
The quantified mangiferin was analyzed by a repeated measures ANOVA. The 
data was analyzed by grouping the control cultivars and test cultivars to perform the 
analysis. The data was grouped according to the stage of development, not region. The 
descriptive statistics for mangiferin content in each stage of development showed that the 
data distribution was not normal (Table 4, Figures 15-22). None of the normality tests 
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were passed (Table 3) and the data was right-skewed. Since the data was right-skewed 
and not normal, the data was unfit for any two-way ANOVA or repeated measures 
ANOVA analysis. Consequently, the data was transformed using the natural log function 
(ln) to create new log values to compare with the repeated measures ANOVA. This 
transformation resulted in the data having a normal distribution in all stages of 
development (Table 4, Figures 23-30). All of the normality tests demonstrated the result 
of transforming values (Table 5). Using the transformed values, a repeated measures 
ANOVA was used to test for differences in infection across stage and variety.  
 
 
 
 
Table 4. Tests of Normality. 
 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Stage 1 .289 36 .000 .718 36 .000 
Stage 2 .252 36 .000 .678 36 .000 
Stage 3 .242 36 .000 .698 36 .000 
Stage 4 .342 36 .000 .534 36 .000 
a. Lilliefors Significance Correction 
 
 
 
Table 5. Descriptive Statistics of the Mangiferin Content of All Mango Peels 
Analyzed During Each Stage of Development. 
 
 Statistic Std. Error 
Stage 1 Mean 6995.10559 1589.379463 
95% Confidence 
Interval for Mean 
Lower Bound 3768.49374  
Upper Bound 10221.71744  
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Variance 90940574.780  
Std. Deviation 9536.276778  
Stage 2 Mean 3733.79569 929.718694 
95% Confidence 
Interval for Mean 
Lower Bound 1846.36640  
Upper Bound 5621.22498  
Variance 31117566.568  
Std. Deviation 5578.312161  
Stage 3 Mean 2842.99487 670.523430 
95% Confidence 
Interval for Mean 
Lower Bound 1481.75994  
Upper Bound 4204.22980  
Variance 16185660.108  
Std. Deviation 4023.140578  
Stage 4 Mean 2490.61067 784.547596 
95% Confidence 
Interval for Mean 
Lower Bound 897.89438  
Upper Bound 4083.32697  
Variance 22158537.477  
Std. Deviation 4707.285574  
 
 
 
 
 
 
 
Figure 20. Stage 1: Distribution of all 
cultivars. 
 
Figure 21. Stage 1: Normal Q-Q plot 
of all cultivars. 
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Figure 22. Stage 2: Distribution of all 
cultivars. 
 
Figure 23. Stage 2: Normal Q-Q plot 
of all cultivars. 
 
 
Figure 24. Stage 3: Distribution of all 
cultivars. 
 
 
Figure 25. Stage 3: Normal Q-Q plot 
of all cultivars. 
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Figure 26. Stage 4: Distribution of all 
cultivars. 
 
 
Figure 27. Stage 4: Normal Q-Q plot 
of all cultivars.
 
Table 6. Descriptive statistics for the Transformed Values of Mangiferin per Stage 
of Development. 
 
 
 
 Statistic
Std. 
Error 
ln_stage1 Mean 7.5112 .33057 
95% Confidence 
Interval for Mean 
Lower Bound 6.8401  
Upper Bound 8.1823  
Variance 3.934  
Std. Deviation 1.98343  
ln_stage2 Mean 6.8500 .35794 
95% Confidence 
Interval for Mean 
Lower Bound 6.1233  
Upper Bound 7.5766  
Variance 4.612  
Std. Deviation 2.14762  
ln_stage3 Mean 6.7389 .32017 
95% Confidence 
Interval for Mean 
Lower Bound 6.0889  
Upper Bound 7.3889  
Variance 3.690  
Std. Deviation 1.92105  
ln_stage4 Mean 6.2762 .34395 
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95% Confidence 
Interval for Mean 
Lower Bound 5.5779  
Upper Bound 6.9744  
Variance 4.259  
Std. Deviation 2.06372  
 
 
Table 7. Tests of Normality for the transformed values of Mangiferin. 
 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic Df Sig. Statistic df Sig. 
ln_stage1 .096 36 .200* .943 36 .063 
ln_stage2 .126 36 .158 .939 36 .048 
ln_stage3 .148 36 .044 .940 36 .050 
ln_stage4 .098 36 .200* .954 36 .136 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
 
 
 
 
Figure 28. Stage 1: Distribution of 
transformed values for of all cultivars. 
 
Figure 29. Stage 1: Normal Q-Q plot 
of transformed values for of all 
cultivars. 
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Figure 30. Stage 2: Distribution of 
transformed values for of all cultivars. 
 
Figure 31. Stage 2: Normal Q-Q plot 
of transformed values for of all 
cultivars. 
 
 
Figure 32. Stage 3: Distribution of 
transformed values for of all cultivars. 
 
Figure 33. Stage 3: Normal Q-Q plot 
of transformed values for of all 
cultivars. 
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Figure 34. Stage 4: Distribution of 
transformed values for of all cultivars. 
 
Figure 35. Stage 4: Normal Q-Q plot 
of transformed values for of all 
cultivars. 
The descriptive statistics for the general linear model of the repeated measures 
ANOVA can be found in Table 8 and the descriptive statistics for the region-stage 
interaction can be found in Table 9. Multivariate tests via the repeated measures 
ANOVA were implemented to determine the significance of the mangiferin content in 
each stage of fruit development and the interaction of the stage of fruit development and 
the region of origin. The tests showed that the stage of fruit development was significant 
but the interaction was not significant (Table 10). Tests of within-subjects contrasts were 
implemented to further confirm the significance of the mangiferin content in each stage 
of fruit development and the region of origin; and to determine the significance of the 
stage of fruit development and the interaction of the stage of fruit development and the 
region of origin in different trends (linear, quadratic, and cubic). The tests showed that 
the stage of fruit development had a significant linear trend (Table 11). The test of 
between-subject effects determined that the region of mango origin was significant 
(Table 12). 
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Table 8. Descriptive Statistics for the General Linear Model. 
 
 
Region Mean Std. Deviation N 
ln_stage1 0 10.2065 .05812 4
1 8.0642 1.61572 8
2 7.0641 1.08588 8
3 6.7570 3.04673 8
4 6.8118 .81105 8
Total 7.5112 1.98343 36
ln_stage2 0 9.7487 .28676 4
1 7.1287 1.50141 8
2 6.7417 1.54902 8
3 5.5952 3.05839 8
4 6.4848 1.47077 8
Total 6.8500 2.14762 36
ln_stage3 0 9.4686 .15470 4
1 7.1459 1.34649 8
2 6.2503 1.30806 8
3 5.7152 2.56570 8
4 6.4795 1.52986 8
Total 6.7389 1.92105 36
ln_stage4 0 9.6330 .08667 4
1 7.0010 .75156 8
2 5.6783 1.43200 8
3 4.9277 2.93300 8
4 5.8192 .55574 8
Total 6.2762 2.06372 36
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Table 9. Region * Stage Descriptive Statistics. 
 
Measure:   Measure_   
Region Stage Mean 
Std. 
Error 
95% Confidence Interval 
Lower Bound Upper Bound
0 1 10.20
7 
.880 8.411 12.002
2 9.749 .956 7.798 11.699
3 9.469 .839 7.758 11.179
4 9.633 .807 7.988 11.278
1 1 8.064 .623 6.795 9.334
2 7.129 .676 5.749 8.508
3 7.146 .593 5.937 8.355
4 7.001 .570 5.837 8.164
2 1 7.064 .623 5.794 8.334
2 6.742 .676 5.362 8.121
3 6.250 .593 5.041 7.460
4 5.678 .570 4.515 6.842
3 1 6.757 .623 5.487 8.027
2 5.595 .676 4.216 6.975
3 5.715 .593 4.506 6.925
4 4.928 .570 3.764 6.091
4 1 6.812 .623 5.542 8.082
2 6.485 .676 5.105 7.864
3 6.480 .593 5.270 7.689
4 5.819 .570 4.656 6.983
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Table 10. Stage vs Stage- Region Interaction: Multivariate Testsa. 
 
Effect Value F 
Hypot
hesis 
df 
Error 
df Sig. 
Partial Eta 
Squared 
Noncent. 
Parameter
Observed 
Powerd 
Stage Pillai's Trace .617 15.594b 3.000 29.000 .000 .617 46.782 1.000
Wilks' Lambda .383 15.594b 3.000 29.000 .000 .617 46.782 1.000
Hotelling's Trace 1.613 15.594b 3.000 29.000 .000 .617 46.782 1.000
Roy's Largest Root 1.613 15.594b 3.000 29.000 .000 .617 46.782 1.000
Stage * Region Pillai's Trace .322 .933 12.000 93.000 .518 .107 11.194 .507
Wilks' Lambda .704 .909 12.000 77.018 .542 .110 9.545 .422
Hotelling's Trace .383 .882 12.000 83.000 .568 .113 10.583 .474
Roy's Largest Root .240 1.861c 4.000 31.000 .142 .194 7.445 .499
a. Design: Intercept + Region  
 Within Subjects Design: Stage 
b. Exact statistic 
c. The statistic is an upper bound on F that yields a lower bound on the significance level. 
d. Computed using alpha = .05 
 
 
 
 
 
 
 
 
47 
 
Table 11. Stage vs Stage- Region Interaction: Tests of Within-Subjects Contrasts. 
 
Measure:   Measure_   
Source Stage 
Type III Sum of 
Squares df
Mean 
Square F Sig. 
Partial Eta 
Squared 
Noncent. 
Parameter
Observed 
Powera 
Stage Linear 22.017 1 22.017 41.073 .000 .570 41.073 1.000
Quadratic .483 1 .483 1.014 .322 .032 1.014 .164
Cubic 1.027 1 1.027 1.049 .314 .033 1.049 .168
Stage * 
Region 
Linear 2.343 4 .586 1.093 .377 .124 4.370 .302
Quadratic 1.910 4 .477 1.001 .422 .114 4.004 .278
Cubic 1.349 4 .337 .344 .846 .043 1.378 .117
Error(Stage) Linear 16.617 31 .536      
Quadratic 14.785 31 .477      
Cubic 30.349 31 .979      
a. Computed using alpha = .05 
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Table 12. Region: Tests of Between-Subjects Effects.     
 
Measure:   Measure_   
Transformed Variable:   Average   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Noncent. 
Parameter 
Observed 
Powera 
Intercept 6789.798 1 6789.798 666.671 .000 .956 666.671 1.000
Region 194.270 4 48.568 4.769 .004 .381 19.075 .918
Error 315.724 31 10.185      
a. Computed using alpha = .05 
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 Pairwise comparisons were implemented to determine if there were any 
significant differences in mangiferin content between the stages of mango fruit 
development (Table 13). Estimated marginal means were used to make these 
comparisons (Figure 36). Stage 1 had a significantly higher mean mangiferin content 
than stages 2-4. Stage 2 had a significantly lower mangiferin content than stage 1 and a 
significantly mean higher mangiferin content than stage 4. Stage 3 had a significantly 
lower mean mangiferin content than stage 1. Stage 4 had a significantly lower mean 
mangiferin content than stages 1 and 2.  
Table 13. Stage: Pairwise Comparisons. 
 
Measure:   Measure_   
(I) Stage (J) Stage 
Mean 
Difference 
(I-J) 
Std. 
Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound
1 2 .641* .198 .017 .084 1.198
3 .769* .212 .006 .173 1.365
4 1.169* .166 .000 .700 1.638
2 1 -.641* .198 .017 -1.198 -.084
3 .128 .251 1.000 -.581 .837
4 .528* .176 .031 .033 1.023
3 1 -.769* .212 .006 -1.365 -.173
2 -.128 .251 1.000 -.837 .581
4 .400 .183 .218 -.115 .915
4 1 -1.169* .166 .000 -1.638 -.700
2 -.528* .176 .031 -1.023 -.033
3 -.400 .183 .218 -.915 .115
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Bonferroni. 
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Figure 36. Region: Estimated Marginal Means. 
 
 
Pairwise comparisons were implemented to determine if there were any 
significant differences in mangiferin content between the different regions of origin 
(Table 14). Region 0 (the controls) had a significantly higher mean level of mangiferin 
than all regions with the exception of region 1. Region 1 had no significant difference 
with any of the other regions. Regions 2, 3, and 4 had significantly lower mean 
mangiferin concentrations than region 0.  
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Table 14. Region: Pairwise Comparisons. 
 
Measure:   Measure_   
(I) 
Region (J) Region 
Mean 
Difference 
(I-J) 
Std. 
Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound
0 1 2.429 .977 .185 -.524 5.382
2 3.331* .977 .018 .378 6.284
3 4.015* .977 .003 1.062 6.968
4 3.365* .977 .017 .412 6.318
1 0 -2.429 .977 .185 -5.382 .524
2 .901 .798 1.000 -1.510 3.312
3 1.586 .798 .557 -.825 3.997
4 .936 .798 1.000 -1.475 3.347
2 0 -3.331* .977 .018 -6.284 -.378
1 -.901 .798 1.000 -3.312 1.510
3 .685 .798 1.000 -1.726 3.096
4 .035 .798 1.000 -2.376 2.446
3 0 -4.015* .977 .003 -6.968 -1.062
1 -1.586 .798 .557 -3.997 .825
2 -.685 .798 1.000 -3.096 1.726
4 -.650 .798 1.000 -3.061 1.761
4 0 -3.365* .977 .017 -6.318 -.412
1 -.936 .798 1.000 -3.347 1.475
2 -.035 .798 1.000 -2.446 2.376
3 .650 .798 1.000 -1.761 3.061
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Bonferroni. 
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 Univariate tests were implemented to further confirm the presence of significantly 
different regions (Table 15). The tests were based on linearly independent pairwise 
comparisons among the estimated marginal means. The tests showed that there was at 
least one significantly different region of origin. 
 Significant differences in mangiferin content between the different regions of 
origin were further confirmed by implementing multiple comparisons tests using Tukey’s 
HSD (Table 16). The multiple comparisons tests showed that region 0 was significantly 
higher than regions 2-4, region 1 had no significant differences with any other region or 
origin, and regions 2-4 were significantly lower than 0.  
 
Table 15. Region: Univariate Tests. 
 
Measure:   Measure_   
 
Sum of 
Squares df 
Mean 
Square F Sig.
Partial Eta 
Squared 
Noncent. 
Parameter 
Observed 
Powera 
Contrast 48.568 4 12.142 4.769 .004 .381 19.075 .918
Error 78.931 31 2.546      
The F tests the effect of Region. This test is based on the linearly independent 
pairwise comparisons among the estimated marginal means. 
a. Computed using alpha = .05 
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Table 16. Region: Multiple Comparisons via Tukey's HSD. 
 
Measure:   Measure_   
Tukey HSD   
(I) 
Region (J) Region 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
0 1 2.4292 .97714 .120 -.3994 5.2579
2 3.3306* .97714 .015 .5019 6.1592
3 4.0154* .97714 .002 1.1868 6.8441
4 3.3654* .97714 .013 .5367 6.1940
1 0 -2.4292 .97714 .120 -5.2579 .3994
2 .9013 .79783 .790 -1.4082 3.2109
3 1.5862 .79783 .295 -.7234 3.8958
4 .9361 .79783 .766 -1.3734 3.2457
2 0 -3.3306* .97714 .015 -6.1592 -.5019
1 -.9013 .79783 .790 -3.2109 1.4082
3 .6848 .79783 .910 -1.6247 2.9944
4 .0348 .79783 1.000 -2.2748 2.3444
3 0 -4.0154* .97714 .002 -6.8441 -1.1868
1 -1.5862 .79783 .295 -3.8958 .7234
2 -.6848 .79783 .910 -2.9944 1.6247
4 -.6501 .79783 .924 -2.9596 1.6595
4 0 -3.3654* .97714 .013 -6.1940 -.5367
1 -.9361 .79783 .766 -3.2457 1.3734
2 -.0348 .79783 1.000 -2.3444 2.2748
3 .6501 .79783 .924 -1.6595 2.9596
Based on observed means. 
 The error term is Mean Square(Error) = 2.546. 
*. The mean difference is significant at the .05 level. 
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 The repeated measures ANOVA showed that the control cultivars were not 
significantly different from each other. To determine if there were any differences in 
mangiferin content per stage of development, a repeated measures ANOVA was 
implemented on the control cultivars alone. The biological replicates were analyzed 
individually to identify any differences in mangiferin content (Table 17). Both biological 
replicates for the cultivar ‘Neelum’ showed no significant difference in mangiferin 
concentrations per stage of development. One biological replicate for the cultivar ‘Zebda’ 
showed that stage 1 had a significantly higher amount of mangiferin than stage 3 and that 
stage 2 had a significantly higher amount of mangiferin than stages 3 and 4. 
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Table 17. Pairwise Comparisons: Cultivar vs Stage of Development. 
 
Measure:   MEASURE_1   
Mango (I) Stage (J) Stage
Mean 
Difference (I-J)
Std. 
Error Sig.b 
95% Confidence 
Interval for 
Differenceb 
Lower 
Bound 
Upper 
Bound 
Zebda_1 1 2 -.860 .653 1.000 -2.795 1.074
3 2.442* .715 .019 .324 4.560
4 1.304 .493 .099 -.157 2.764
2 1 .860 .653 1.000 -1.074 2.795
3 3.302* .720 .001 1.169 5.436
4 2.164* .588 .010 .423 3.905
3 1 -2.442* .715 .019 -4.560 -.324
2 -3.302* .720 .001 -5.436 -1.169
4 -1.138 .569 .364 -2.824 .547
4 1 -1.304 .493 .099 -2.764 .157
2 -2.164* .588 .010 -3.905 -.423
3 1.138 .569 .364 -.547 2.824
Zebda_2 1 2 -1.028 .653 .796 -2.963 .906
3 -.015 .715 1.000 -2.133 2.103
4 -.195 .493 1.000 -1.656 1.266
2 1 1.028 .653 .796 -.906 2.963
3 1.013 .720 1.000 -1.120 3.147
4 .833 .588 1.000 -.908 2.574
3 1 .015 .715 1.000 -2.103 2.133
2 -1.013 .720 1.000 -3.147 1.120
4 -.180 .569 1.000 -1.865 1.505
4 1 .195 .493 1.000 -1.266 1.656
2 -.833 .588 1.000 -2.574 .908
3 .180 .569 1.000 -1.505 1.865
Neelum_
1 
1 2 .216 .653 1.000 -1.719 2.150
3 .831 .715 1.000 -1.287 2.950
4 .613 .493 1.000 -.847 2.074
2 1 -.216 .653 1.000 -2.150 1.719
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3 .616 .720 1.000 -1.518 2.749
4 .398 .588 1.000 -1.343 2.139
3 1 -.831 .715 1.000 -2.950 1.287
2 -.616 .720 1.000 -2.749 1.518
4 -.218 .569 1.000 -1.903 1.467
4 1 -.613 .493 1.000 -2.074 .847
2 -.398 .588 1.000 -2.139 1.343
3 .218 .569 1.000 -1.467 1.903
Neelum_
2 
1 2 .700 .653 1.000 -1.234 2.634
3 .645 .715 1.000 -1.474 2.763
4 .534 .493 1.000 -.927 1.994
2 1 -.700 .653 1.000 -2.634 1.234
3 -.056 .720 1.000 -2.189 2.078
4 -.166 .588 1.000 -1.908 1.575
3 1 -.645 .715 1.000 -2.763 1.474
2 .056 .720 1.000 -2.078 2.189
4 -.111 .569 1.000 -1.796 1.574
4 1 -.534 .493 1.000 -1.994 .927
2 .166 .588 1.000 -1.575 1.908
3 .111 .569 1.000 -1.574 1.796
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Bonferroni. 
 
 
Anti-fungal Assay Results 
 No anti-fungal activity was exhibited when the extracts and mangiferin standards 
were tested against four strains of Colletotrichum gloeosporioides Penz. and Sacc. In 
Penz. Consequently, no statistical analyses were performed. 
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VII. DISCUSSION AND CONCLUSION 
 
Accuracy Determination 
With the exception of samples spiked at the LOQ level, the error (represented by 
the coefficient of variance or CV) of the other samples were acceptable. The low 
coefficient of variance led to the conclusion that the extraction method had high 
reproducibility. The coefficient of variance of the LOQ may have been a consequence of 
the quantified amount of mangiferin recovered being below the limit of quantification.  
The percent recoveries followed a Gaussian pattern. The lower levels had low 
mangiferin concentrations, the middle level (5LOQ) had the highest amount of 
mangiferin, and the higher levels had low amounts of mangiferin. The low percent 
recovery of the samples spiked at the LOQ level was a result of the mangiferin remaining 
in the sample composite. The percent recoveries that were greater than 100% was caused 
by the extraction of the mangiferin spiked onto the samples as well as mangiferin that 
naturally occurred in the samples. 
 
Mangiferin Quantitation and Statistical Analysis 
 It was hypothesized that the mangiferin content would be the highest in mangoes 
originating from Region 4 (Pacific/South America/West Indies) and the lowest in 
originating Region 2 (Florida/Hawaii/Israel) during all four stages of development. Since 
all of the mangoes were collected from the same location, any variability due to local 
environmental effects (e.g., UV, precipitation, nutrient absorption, and soil) would 
essentially be the same in all of the mangos collected.  Therefore, any significant 
58 
 
differences in mangiferin content would be the result of genetic differences. Those 
genetic differences were outlined in the dendrogram constructed by Schnell et al. (2006) 
and utilized to group the mangoes into their respective “regions”.  Mangoes from Region 
4 were cultivated for a considerable period of time in and around the equator. These areas 
are consistently exposed to high amounts of sunlight thereby increasing the probability of 
oxidative damage to the trees. Mangiferin is a free-radical scavenger so over time, the 
trees could have increased their mangiferin production considerably to protect the tissues 
from damage. Mangoes from Region 2 are north of the equator. They are not exposed to 
as much ultraviolet radiation as mangoes from the other regions so there was no need for 
mangiferin production to increase. As such, the mangiferin content in this region was 
expected to be considerably lower than the other regions.  
According to the various tests implemented via the repeated measures ANOVA, 
the control cultivars had significantly higher concentrations of mangiferin than all other 
regions except region 1. Amongst the test cultivars, there were no significant differences 
between the different regions in any of the stages of development. These results show 
that the region of origin of a mango may be insignificant. The standard error for each 
region was considerable because of the high variability in mangiferin content per cultivar. 
For instance, the test cultivar with the highest overall mangiferin content, ‘Tommy 
Atkins’, was from the same region as the test cultivars with the lowest overall mangiferin 
content, ‘Fukuda’. No regional differences in mangiferin content may also be because the 
sample size (144), effect size (0.25), and power (0.8) were too small to detect any 
significant differences. If there are any significant differences, another analysis will need 
to be implemented with a larger sample size with a more diverse array of cultivars. By 
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increasing the sample size, the effect size will decrease and the power will increase. By 
implementing these changes, when the data are analyzed by the repeated measures 
ANOVA, significant differences that were undetectable before will be detectable. 
 According to the various tests implemented via the repeated measures ANOVA, 
there were statistical differences in mangiferin content between the stages of mango fruit 
development. Stage 1 had a significantly higher mean mangiferin content than stages 2-4; 
stage 2 had a significantly lower mangiferin content than stage 1 and a significantly mean 
higher mangiferin content than stage 4; stage 3 had a significantly lower mean mangiferin 
content than stage 1; and stage 4 had a significantly lower mean mangiferin content than 
stages 1 and 2. Mangiferin may play a pivotal role up to the first stage of development 
that collections took place (mangos were collected after fruit approximately 1-2 months 
after fruit budding occurred). Mangiferin concentrations during this stage of development 
could potentially be indicative of the mango tree’s ability to resist anthracnose. During 
this stage, ‘Tommy Atkins’, a moderately resistant variety, had the highest amount of 
mangiferin amongst the test cultivars at 21216ppm. ‘Fukuda’, a susceptible variety, had 
the lowest amount of mangiferin at 48.813ppm. 
The control cultivars ‘Neelum’ and ‘Zebda’ were reportedly highly susceptible 
and highly resistant to mango anthracnose, respectively. As such, it was hypothesized 
that the mangiferin content would be considerably low and considerably high, 
respectively. The analysis showed that (1) the mangiferin concentrations of the control 
cultivars were considerably higher than any other cultivar analyzed and (2) there were no 
significant differences between the control cultivars in any stage of development. The 
mangiferin content of each stage of development were not statistically different for either 
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cultivar. The only exception was that the one biological replicate for the cultivar ‘Zebda’ 
showed that stage 1 had a significantly higher amount of mangiferin than stage 3 and that 
stage 2 had a significantly higher amount of mangiferin than stages 3 and 4. In order to 
determine if ‘Zebda’ has significantly different amounts of mangiferin during different 
stages of development, more samples need to be collected and analyzed. 
The mangiferin concentrations of ‘Zebda’ and ‘Neelum’ superseded the 
concentrations expected of these cultivars. Also, the mangiferin content of these 
accessions did not significantly decrease like the test cultivars did. According to 
literature, the higher the amount of mangiferin, the greater the resistance of the mango 
plant to biotic and abiotic stressors. Contrariwise, if mangiferin accumulates excessively 
at the site of infection, this results in the manifestation of disease symptoms via a wide 
range of biological and physiological aberrations in the host cells. ‘Zebda’ and ‘Neelum’ 
may have mangiferin contents that lie on the border of concentrations that defend the 
plant against biotic and abiotic threats and concentrations that cause damage to the plant.  
 
Anti-fungal Assay 
 It was hypothesized that there would be a negative correlation between fungus 
growth and mangiferin concentrations. The extracts were not effective against the four 
different strains of C. gloeosporioides Penz. and Sacc. In Penz. in the assay. This does 
not mean that mangiferin is not effective against C. gloeosporioides. Mangiferin may 
have another mode of action that is effective against the Colletotrichum spp. That mode 
of action may be similar to the mode mangiferin utilizes to combat the fungus responsible 
fofr mango malformation.  When Fusarium mangiferae Britz., M.J. Wingf. & Marasas, 
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the fungus responsible for mango malformation, is present, mangiferin removes the 
nutrition source of the fungus by oxidizing into polymeric quinones (along with gallic 
acid conjugates). These quinones cause the collapse of adjoining cells, thereby preventing 
the multiplication of the fungus. Mangiferin also stops the breakdown of host starch. This 
process removes the nutrition source the pathogen requires to grow and sporulate. 
 In summation, the validated method utilized to extract mangiferin from mango 
peels had a high, reproducible percent recovery. According to the repeated measures 
ANOVA, there were no statistical differences between mangiferin content and the 
regions of origin. There were, however, statistical differences between mangiferin 
content and stages of mango fruit development. Mangiferin concentrations were 
significantly higher in stage 1 than in stages 2-4 and significantly higher in stage 2 than in 
stage 4 of development. The control cultivars, ‘Neelum’ and ‘Zebda’, had no significant 
differences in any stage of development. Some significant differences in mangiferin 
content during each stage of development were observed for ‘Zebda’, but further analyses 
need to be implemented to determine if there are indeed any significant differences 
during the stages of development. The extracts exhibited no anti-fungal activity in the 
antifungal assay employed. If mangiferin’s mode of action is similar to its mode of action 
against the fungus responsible for mango malformation then the absence of any anti-
fungal properties exhibited in this assay should be expected.  
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RAW DATA 
 
Cultivar 
Biological 
Replicate Region Stage 1 Stage 2 Stage 3 Stage 4 
Peach 1 1 9855.444 2101.789 1587.328 667.770
2 1 4947.635 3245.512 1521.856 1071.749
Pere Louis 1 1 597.473 69.067 103.676 324.705
2 1 164.731 232.967 286.209 554.007
Turpentine #7 1 1 19946.808 4023.396 5596.370 2584.298
 2 1 12427.740 4854.113 4096.957 2620.439
Toledo 1 1 3003.331 1469.231 2548.207 1728.165
 2 1 2917.125 1859.931 1604.859 1399.058
Nam Tan Teen 1 2 4805.879 7634.840 852.918 988.089
 2 2 3892.465 158.429 380.705 660.953
Nam Doc Mai 1 2 325.233 64.432 230.045 43.378
 2 2 1442.028 648.832 41.033 49.674
Myatryaut 1 2 211.297 1350.047 1183.350 172.000
 2 2 1260.413 836.339 350.651 131.488
Katar Rum Rung 1 2 897.186 1317.258 1943.778 1554.864
 2 2 1666.400 3522.752 2102.132 1081.450
Tommy Atkins 1 3 20864.306 5649.948 5098.900 3429.206
 2 3 21567.834 5677.629 4123.126 3974.436
Fukuda 1 3 55.127 8.802 21.536 6.421
 2 3 42.499 8.192 24.048 6.336
Bombay  1 3 44.116 23.147 30.678 20.380
 2 3 67.365 40.369 39.510 9.316
Maya 1 3 17755.838 3090.348 1766.870 1055.951
68 
 
 2 3 5379.928 4120.430 3081.829 1187.937
Sabre 1 4 825.171 71.477 669.937 173.458
 2 4 1274.903 127.749 1609.349 230.107
Diab 1 4 1571.916 783.774 3700.642 337.770
 2 4 1064.143 411.211 3963.821 426.462
Bullock's Heart 1 4 1319.082 4732.478 200.642 261.285
 2 4 2617.103 4076.706 130.192 974.048
Jehangir 1 4 330.640 734.235 1131.155 224.009
 2 4 231.034 813.679 69.589 503.870
Zebda 1 0 28545.899 23772.566 12397.64 13451.55
 2 0 24923.819 19448.142 10880.81 15510.26
Neelum 1 0 27572.860 15087.424 15787.58 15921.27
 2 0 27409.031 12349.405 13189.87 16325.83
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TECHNICAL PROCEDURE 
Natural Products Isolation 
 
Effective Date: 
01-26-15 
Quantification of Mangiferin in 
Mango Peel Page 1 of 9 
 
I. Scope 
 
The extraction method used is applicable to the quantitative determination of 
mangiferin in mango peels.  The method has a validated limit of detection (LOD) 
of 13.32 ppm and a limit of quantitation (LOQ) of 39.99 ppm and has been 
validated over a concentration range of 39.99 ppm-399.9 ppm. This method 
generates approximately 4mL of organic waste per sample. 
 
 
 
Mangiferin 
 
 
 
II. Principle 
A 1 gram sample is extracted with 50:50 Acetonitrile:Water. The extract is 
sonicated for 15 min, placed on a shaker overnight, vortexed, and centrifuged for 
5 min (4500rpm). A 1 mL aliquot is transferred to an autosampler vial and 
analyzed by Ultra High-Performance Liquid Chromatography coupled with an 
Electrospray Ionizer-Mass Spectrometer with UV detection at 242nm, 367nm, 
and3D Field as well as MS-MS detection of the base peak 405m/z. 
 
 
 
III. Process Description 
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a. Sample Preparation 
 
i. Apparatus and Reagents 
 
• Analytical Balance 
• 50mL disposable centrifuge tube (Fisher Scientific cat#: 
05-539-12) 
• Liquid Nitrogen 
• Dewar vessel 
• Metal Mortar 
• Ceramic Pestle 
• Funnel 
• Spatula 
• Surgical Steel Blades 
 
ii. Mixing and Preparation of Samples 
 
• Using a surgical steel blade, remove viable peel (peel that 
is unbroken and does not have fungi growing on it) 
• Adding bits at a time, grind the entire sample in liquid 
nitrogen using a metal mortar and ceramic pestle 
• Transfer grinded tissue into a 50mL centrifuge tube 
• Store sample in cryogenic freezer if extraction is not 
planned for the same day 
**Samples must be thawed prior to extraction 
• Clean laboratory equipment between samples 
**Clean the metal mortar, ceramic pestle, funnel, and 
spatula with soap and water then solvent rinse 
 
We have performed the operations stated in this section. 
Initial    Date      
 
 
 
iii. Weighing of Sub-Samples 
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• Verify balance suitability and record appropriate 
documentation in balance logbook. 
• Place a 50mL disposable centrifuge tube into a beaker and 
tare the analytical balance 
• Transfer 1 gram of sample into the 50mL centrifuge tube 
• Record weight on sample worksheet. 
 
We have performed the operations stated in this section. 
Initial    Date      
 
 
b. Sample Processing 
i.  Apparatus and Reagents 
 
•  50:50 Acetonitrile:Water 
• 15mL disposable centrifuge tubes 
• 5mL pipette 
• Vortex 
• Sonicator 
• Shaker 
• Centrifuge 
 
ii. Sample Extraction 
 
• To the sample, add 5mL of 50:50 acetonitrile:water. 
• Sonicate for 15min. 
• Place on shaker overnight (setting: low) 
• Vortex the sample. 
• Centrifuge the sample for 5min (setting: 4500rpm). 
• Transfer supernatant layer to a 15mL disposable centrifuge 
tube. 
 
 
• Centrifuge the sample for 5min (setting: 4500rpm). 
• Add 0.5mL of supernatant to HPLC vial with 1.5mL of 
50:50 Acetonitrile:Water 
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We have performed the operations stated in this section. 
Initial    Date      
 
c. Sample Fortification 
 
i. Apparatus and Reagents 
 
• 2mL, 4mL Class A volumetric pipettes 
• 50mL volumetric flasks 
• Brown bottles 
• 50:50 Acetonitrile:Water 
• 1000µg/mL Mangiferin stock solution in 50:50 
Acetonitrile:Water 
 
ii. Preparation of Fortification Solution 
 
• Using an eppendorf pipette, pipette 1.4mL of a 1000µg/mL 
Mangiferin stock solution into a 50mL volumetric flask and 
dilute to the mark with 50:50 Acetonitrile:Water. 
Concentration should be approximately 28µg/mL 
mangiferin 
• Transfer solution to the appropriate size brown bottle and 
label 
• Record activity on sample worksheet 
 
iii. Preparation of Standard Check 
 
• Using an eppendorf pipette, pipette 1.4mL of a 1000 µg/mL 
Mangiferin stock solution into a 50mL volumetric flask and 
dilute to the mark with 50:50 Acetonitrile:Water. 
Concentration should be approximately 28µg/mL 
mangiferin 
• Transfer solution to the appropriate size brown bottle and 
label 
• Record activity on sample worksheet 
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iv. Determination of Percent Recovery of Mangiferin 
 
• To the blank composite, spike 5mL of the fortification 
solution 
• Record activity on the sample worksheet 
Amount Spiked of Fortification Standard (ppm) = (ହ௠௅)(
మఴഋ೒
೘ಽ )
ଵ௚	௦௔௠௣௟௘  
Amount Spiked of Fortification Standard (ppm) = 140ppm 
Mangiferin 
 
We have performed the operations stated in this section. 
Initial    Date      
 
d. Instrumental Analysis 
 
i. Apparatus and Reagents 
 
• Thermo Scientific UltiMate™ 3000 UPLC equipped with a 
photodiode array detector 
• Thermo Scientific LTQ Heated Electrospray Ionizer 
(HESI) coupled with a Line Ion Trap Mass Spectrometer 
• Analytical Column, Zorbax 300SB-C18 250 x 4.6mm, 5µm 
• 0.1% Formic Acid in HPLC Water 
• 0.1% Formic Acid in Acetonitrile 
• 15mL disposable centrifuge tubes 
• Autosampler vials 
• 50:50 Acetonitrile:Water 
• 0.5, 1, 2, 3, 8, and 10mL Class A volumetric pipettes 
 
 
 
ii. Typical Operating Conditions 
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Parameter  
Instrumentation 
Thermo Scientific UltiMate™ 3000 UPLC equipped with a 
photodiode array detector 
Thermo Scientific LTQ Heated Electrospray Ionizer (HESI) 
coupled with a Line Ion Trap Mass Spectrometer 
Column Zorbax 300SB-C18 250 x 4.6mm, 5µm 
Column 
Temperature 25°C 
Mobile Phase Solvent A: 0.1% Formic Acid in Water 
 Solvent B: 0.1% Formic Acid in Acetonitrile 
Gradient Time    %Solvent A     %Solvent B 
 
 0.00     95.0                   5.00 
 1.00     95.0                   5.00 
 15.00   0.00                   100.0 
 9.00     0.00                   100.0 
 16.00   95.0                   5.00 
 19.00   95.0                   5.00    
Flow Rate 0.500 mL/min 
Injection Volume 1µL 
MS Base Peak 423m/z 
MS/MS Base Peak 405m/z 
Normalized 
Collision Energy 35.0 V 
MS Polarity Positive 
UV Wavelengths 242nm, 367nm, 3D Field 
Run Time 19 min 
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iii. Preparation of Bench Standards 
 
Using a Class A volumetric pipette, pipette 2mL of a 5000ppm stock of mangiferin into a 15mL disposable centrifuge tube 
and add 8mL of 50:50 acetonitrile:water. Label appropriately. Concentration should be approximately 1000ppm mangiferin. Shelf 
life is to be 6 months. This solution is the bench intermediate. Prep Date:     
 
Working 
Standard 
Initial 
Concentration
Amount 
Added 
Solvent 
Amount Solvent 
Final 
Concentration
Target 
Concentration
Prep 
Date 
LOQ Std 
Mangiferin 
 
___________ 
(ppm) 
0.5mL Bench 
Intermediate 12.0mL 
50:50 
ACN:H2O 
 
___________ 
(ppm) 
40ppm  
5LOQ Std 
Mangiferin 
 
___________ 
(ppm) 
1.0mL Bench 
Intermediate 4.0mL 
50:50 
ACN:H2O 
 
___________ 
(ppm) 
200ppm  
10LOQ Std 
Mangiferin 
 
___________ 
(ppm) 
2.0mL Bench 
Intermediate 3.0mL 
50:50 
ACN:H2O 
 
___________ 
(ppm) 
400ppm  
 
 
 
݌݌݉ =
ఓ௚
௠௅ (ܤ݁݊ܿℎ	ܵݐܽ݊݀ܽݎ݀)
଴.ଶ௚
௠௅ (ܨ݈݅݊ܽ	ܵܽ݉݌݈݁	ܵ݅ݖ݁)
 
 
 
 
We have performed the operations stated in this section. 
Initial    Date      
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iv. System Suitability 
Criteria Expected Analyst Review 
Standard check 5% RSD ≥   Y            N 
Peak Area at LOQ of first 3 
standards 
 5% RSD ≥    Y            N 
Standard curve at 1, 5, and 10 
LOQ 
R2 ≥ 0.98   Y            N 
 
• Suitability is not met unless all criteria have been checked 
“Yes” 
• If suitability is not met, perform maintenance and run again 
• Do not proceed to Analysis until suitability has been 
achieved 
 
We have performed the operations stated in this section. 
Initial    Date      
 
v. Analysis 
 
• The 5LOQ standard is to be placed after every 5 samples 
and at the end of analysis 
• Samples found to be outside of the calibration curve are to 
be diluted appropriately and the dilution factor applied to 
the final amount 
 
vi. Calculations 
 
• To determine the percent recovery of the Fortified Sample, 
use the following calculation: 
 
Percent Recovered = ஺௠௢௨௡௧	௙௢௨௡ௗ	(௣௣௠)஺௠௢௨௡௧	௦௣௜௞௘ௗ	(௣௣௠) ݔ100%  
 
• To determine the amount of mangiferin, use the following 
calculation: 
 
Amount of mangiferin = (Amount found (ppm) x Dilution factor)/ 
Recovery Factor 
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vii. System Clean Up  
 
• In order to prevent matrix build up on the column, the 
system must be cleaned after each group. Below is a table 
with the operating conditions: 
 
Parameter  
Column 
Temperature 25°C 
Mobile Phase Solvent A: 0.1% Formic Acid in Acetonitrile 
Flow Rate 1.000 mL/min 
Run Time 45 min 
 
 
viii. Data Package Assembly 
 
• A copy of the sample worksheet and accompanying field 
forms 
• A copy of the appropriate technical procedure 
• A printout of the sequence file used for analysis 
• A printout of the calibration table for the reporting column 
• A printout of the extended statistics of the peak height for 
mangiferin 
• A printout of chromatograms supporting system suitability 
(3 LOQ standard injections, linearity curve, and standard 
check) 
• A printout of chromatograms supporting sample analysis 
• A printout of calculation spreadsheet if applicable 
• A printout of report 
 
 
We have performed the operations stated in this section. 
Initial    Date      
 
IV. Records 
 
Data Package 
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SAMPLE REPORT GENERATED BY SOFTWARE 
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